Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GMP
Manufacturing
Gritstone's BARDA-funded COVID vaccine hit with delay
Gritstone opted to kick off the study in the fall instead of this quarter to "allow use of fully GMP-grade raw materials," according to the company.
Zoey Becker
Feb 12, 2024 1:10pm
EuroAPI gets an early lesson in handling production deficiencies
Dec 7, 2022 11:00am
Biologics delivery startup Elektrofi bags $40M for clinical push
Jun 14, 2022 10:30am
Novo's Wegovy may not reach many new patients early next year
Dec 20, 2021 9:45am
Bionova aims to scale up commercial production at its HQ
Jul 16, 2020 10:35am
FDA knocks Altaire for 'tape and foil' contraptions, data flaws
May 27, 2020 9:35am